Editor information Editors and Affiliations Rights and permissions Copyright information 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG About this chapter Cite this chapter Fitchett, D
Work by Gabery and colleagues (JCI Insight, 2020) using labelled peptide found access to hindbrain and hypothalamic regions including the area postrema and subfornical organ, indicating central nervous system engagement rather than a purely peripheral mechanism
Some patients reach their target dose at 0.5 mg weekly, while others benefit from 1.0 mg or 1.7 mg
Discussion Here, we report a novel analysis of GLP-1 agonist and drinking related posts made to the social media platform reddit
Dont get caught up in the marketing hype for unproven alternatives
Inclusion of a substance on the FDA's 503A Bulks List, if adopted by the FDA, does not constitute FDA approval of any drug product or therapy